🔎 Trials Near Me

Akèy › Kolit Ulseratif › Ohio › Parma

Etid klinik pou Kolit Ulseratif nan Parma, OH

10 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Parma (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ap rekriteFaz 4
  • NorthShore Gastroenterology Research, LLC, Westlake · 11 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Site US-027, Westlake · 11 mi lwen
  • Site US-025, Brunswick · 13 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Gastro Intestinal Research Institute of Northern Ohio /ID# 283860, Westlake · 11 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07697456

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3
  • Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake · 11 mi lwen
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake · 11 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • Gastro Intestinal Research Institute of Northern Ohio, LLC., Westlake · 11 mi lwen
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • North Shore Gastroenterology Research - Site Number: 8400130, Westlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07185009

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • North Shore Gastroenterology Research - Site Number: 8400130, Westlake · 11 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Ap rekriteEtid obsèvasyon
  • Gastro Intestinal Research Institute of Northern Ohio, LLC, Westlake · 11 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Gastro Intestinal Research Institute of Northern Ohio,, Westlake · 11 mi lwen
Laj 22 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT06810518

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Parma

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.